Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study-Reference-Cited by-同舟云学术

Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study

Published:2016-10 Issue: Volume:12 Page:263-269
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Packham David K.,Fraser Ian R.,Kerr Peter G.,Segal Karen R.

Funder

Mesoblast, Inc.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference27 articles.

1. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy;Brenner;NEJM,2001

2. Rationale of mesenchymal stem cell therapy in kidney injury;Cantaluppi;Am. J. Kidney Dis.,2013

3. A novel monoclonal antibody (STRO-3) identifies an isoform of tissue non-specific alkaline phosphatase expressed by multipotential bone marrow stromal stem cells;Gronthos;Stem Cells Dev.,2007

4. Challenges and opportunities for stem cell therapy in patients with chronic kidney disease;Hickson;Kidney Int.,2016

5. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group;Kidney Int. Suppl.,2013

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential of Anti-Inflammatory DC Immunotherapy in Improving Proteinuria in Type 2 Diabetes Mellitus;Vaccines;2024-08-27

2. Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets;International Journal of Molecular Sciences;2024-08-20

3. Mesenchymal stem cells biological and biotechnological advances: Implications for clinical applications;European Journal of Pharmacology;2024-08

4. Diabetic nephropathy: Current treatments and tissue engineering strategies;Journal of Applied Biotechnology & Bioengineering;2024-07-01

5. Case Report: Allogenic Wharton's jelly mesenchymal stem cell and exosome therapy are safe and effective for diabetic kidney failure;F1000Research;2024-04-24